Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TCNNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trulieve Cannabis Corp. filings document the regulatory record of a British Columbia cannabis issuer operating as a vertically integrated multi-state operator in the U.S. Recent Form 8-K reports cover operating results, Regulation FD presentations, material definitive agreements, executive compensation matters, and board or officer transitions.
Proxy filings describe annual meeting matters, director elections, executive compensation, equity awards, and shareholder governance. Debt-related filings disclose senior secured notes due 2030, indenture terms, subsidiary guarantees, and related capital-structure obligations tied to Trulieve and its restricted subsidiaries.
Reese Jan, identified as Chief Financial Officer and a director of Trulieve Cannabis Corp. (TRUL), filed an Initial Statement of Beneficial Ownership on Form 3 reporting no ownership of the issuer's common stock as of the 09/08/2025 event date. The filing references an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by Eric Powers as attorney-in-fact on 09/30/2025.